DanCann Pharma A/S announced at the EGM the Board of Directors appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors. Jeppe Krog Rasmussen is Born in 1995. Founder and Chief Executive Officer (CEO) in DanCann Pharma A/S since the Company's foundation back in March 2018.

Jeppe Krog Rasmussen is responsible for the strategic direction and operational execution of all processes relevant to DanCann Pharma. He was a member of the Company's Board of Directors during the years 2020-2022. Jeppe Krog Rasmussen is a serial entrepreneur with strong experience from starting and building companies as well as working and investing in complex industries.

In addition to DanCann Pharma Jeppe Krog Rasmussen runs his investment company, XIGNOTUS CAPITAL ApS, where he manages his investment portfolio. Alexander Born in 1983. Professional investor since 2016.

Alexander Schoeneck is the chairman of the board in JEQ Capital, a fund with focus on small companies in an early stage. Alexander is also a board member in Corpura Fondkommission, EllWee AB (listed on Nasdaq First North), JEQ Capital Holding, Corpura Holding, Campingstugan Invest, Black Lion Media Group AB, Glassaparken AB and JJV Invest AB. Alexander has been part of DanCann Pharma's journey from the beginning and has always worked as an advisor for founder and CEO Jeppe Krog Rasmussen.

Alexander has great experience when it comes to the financial markets, corporate finance and investor relations.